These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12623760)

  • 1. l-Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes.
    Dragoni S; Bellik L; Frosini M; Sgaragli G; Marini S; Gervasi PG; Valoti M
    Xenobiotica; 2003 Feb; 33(2):181-95. PubMed ID: 12623760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl.
    Valoti M; Fusi F; Frosini M; Pessina F; Tipton KF; Sgaragli GP
    Eur J Pharmacol; 2000 Mar; 391(3):199-206. PubMed ID: 10729359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL/6 mouse brain microsomal preparations.
    Dragoni S; Bellik L; Frosini M; Matteucci G; Sgaragli G; Valoti M
    J Neurochem; 2003 Sep; 86(5):1174-80. PubMed ID: 12911625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes.
    Dragoni S; Materozzi G; Pessina F; Frosini M; Marco JL; Unzeta M; Sgaragli G; Valoti M
    J Pharm Pharm Sci; 2007; 10(4):473-85. PubMed ID: 18261369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes.
    Taavitsainen P; Anttila M; Nyman L; Karnani H; Salonen JS; Pelkonen O
    Pharmacol Toxicol; 2000 May; 86(5):215-21. PubMed ID: 10862503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6.
    Grace JM; Kinter MT; Macdonald TL
    Chem Res Toxicol; 1994; 7(3):286-90. PubMed ID: 8075358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P450 phenotyping of the metabolism of selegiline to desmethylselegiline and methamphetamine.
    Benetton SA; Fang C; Yang YO; Alok R; Year M; Lin CC; Yeh LT
    Drug Metab Pharmacokinet; 2007 Apr; 22(2):78-87. PubMed ID: 17495414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
    Yoshida T; Yamada Y; Yamamoto T; Kuroiwa Y
    Xenobiotica; 1986 Feb; 16(2):129-36. PubMed ID: 3083608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
    Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
    J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
    Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
    Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N-demethylation.
    Schmider J; Greenblatt DJ; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1996 Jun; 41(6):593-604. PubMed ID: 8799527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the disposition of A novel cysteine protease inhibitor.
    Jacobsen W; Christians U; Benet LZ
    Drug Metab Dispos; 2000 Nov; 28(11):1343-51. PubMed ID: 11038163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment.
    Bu HZ
    Curr Drug Metab; 2006 Apr; 7(3):231-49. PubMed ID: 16611019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
    Feierman DE; Lasker JM
    Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
    Labroo RB; Thummel KE; Kunze KL; Podoll T; Trager WF; Kharasch ED
    Drug Metab Dispos; 1995 Apr; 23(4):490-6. PubMed ID: 7600917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes.
    Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD
    Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
    Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
    Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cytochromes P450 2D6, 2B6 and 2C19 in the metabolism of (-)-deprenyl and N-methyl,N-propargylphenylethylamine.
    Rittenbach KA; Baker GB
    Drug Metab Lett; 2007 Apr; 1(2):97-100. PubMed ID: 19356027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
    Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
    Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.